Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)

TOPICS

  • Topics
  • Activity report
  • Results
  • Acknowledgement
2024.10.11
A panel discussion will be held at the BioJapan venue in collaboration with the Life Science Incubation Council. We look forward to your participation.
2024.10.09 - 11
We will be exhibiting at BioJapan. We look forward to seeing you at Pacifico Yokohama Exhibition Hall A-42.
2024.09.27
We participated in the “Pre-EXPO Medical care in the Future."
2024.09.19-09.21
Participated in the 83rd Annual Meeting of the Japanese Cancer Association to promote the KENTO Imaging Support Center.
2024.09.18
As part of our support for startup creation/growth promotion, we held a Startup Seminar (special edition).
2024.09.05
The COI-NEXT Program (NCVC) × LSIC 2024 results report meeting was held.
2024.09.05
A site visit to support the promotion of startup creation/growth under the Co-Creation Opportunity Formation Support Program (COI-NEXT) was held. In addition, a mentoring event was held for the three recipients of the program.
2024.08.28
As part of our support for startup creation/growth promotion, we held the 1st Startup Seminar (total of 5 sessions).
2024.07.19
The PI Training Program_Second Progress Meeting was held for presentations and lively discussions.
2024.07.18

The COI-NEXT (Co-Creation Opportunity Formation Support Program) Policy Focus Area (Full-Scale) Site Visit was held, where the PO, Deputy PO, AD, and MEXT staff gave advice and engaged in a lively exchange of opinions. Participating companies were also invited to attend.
Number of participants: 91 (on-site: 53, online: 38)

2024.05.17
The PI Training Program_Fist Progress Meeting was held for presentations and lively discussions.
2024.05.09
The third progress report meeting on the Support and Screening Committee for Startup Creation was held.

Report on participating in the " Pre-EXPO Medical care in the Future "

On Friday, September 27th, we participated in the “Future Medical Pre-EXPO” held at Nakanoshima Qross. This international event aims to promote the potential and efforts of life sciences in Osaka and Kansai to the Kansai Consul General and industry, as well as to deepen exchanges between overseas stakeholders and companies.
At this event, PL Mochizuki gave a presentation as the leader of the Biocommunity Kansai (BiocK) Subcommittee on Digital Biohealth. We also exhibited posters promoting the COI-NEXT program (NCVC).

L) PL Mochizuki's presentation   R) Posters L) PL Mochizuki's presentation   R) Posters

L) Poster exhibition venue   R) Official mascot of the Osaka-Kansai Expo (MYAKU-MYAKU) L) Poster exhibition venue   R) Official mascot of the Osaka-Kansai Expo (MYAKU-MYAKU)

Startup Seminar [Special Edition] Report

On Wednesday, September 18th, we held a "Startup Seminar [Special Edition]".
This time, we invited speakers representing Mayo Clinic, the world's largest non-profit, comprehensive medical group in the United States, to speak about collaboration between the hospital and Japanese companies, and support for Japanese startups expanding into the US.In addition to clinical work, Mayo Clinic is engaged in a variety of research programs, translational research, and building an ecosystem for medical startups.

This time, more than 50 people participated, even though the event was held early in the morning.
We look forward to seeing you at the next Startup Seminar.

Startup Seminar [Special Edition] Report

Startup Seminar [Special Edition] Report

COI-NEXT (NCVC) x LSIC 2024 Results Reporting Session

On Thursday, September 5th, the “2024 Results Reporting Session” was held at the National Cerebral and Cardiovascular Center as part of our support for startup creation.
This time, the session was co-hosted with the Life Science Incubation Council (LSIC) and was held in a hybrid format, both on-site and online. The content of the session provided a deeper understanding of the importance of overseas ecosystems and collaborative networks, and lively exchanges of opinions took place in a very successful environment.

We will continue to work with LSIC to provide support with an awareness of collaboration with overseas companies.

COI-NEXT (NCVC) x LSIC  2024 Results Reporting Session

COI-NEXT (NCVC) x LSIC  2024 Results Reporting Session

FY2024 Startup Creation Support Site Visit and Event Report

On Thursday, September 5th, a site visit for the "2024 Startup Creation/Growth Promotion Support" was held at the National Cerebral and Cardiovascular Center.
This time, the event was held in a hybrid format, combining on-site and online sessions, and representatives from the JST and MEXT participated, resulting in a lively exchange of opinions.

After the site visit, as part of the startup support efforts, Toru Seo (Newsight Tech Angels Inc.) was invited to hold a mentoring event for those selected for the support project. Specific discussions were held on commercialization, including how to capture the market, marking an important step towards future business development.

Based on the advice we received, we will continue to work hard towards further development of our base.

The site visit venue The site visit venue

Mentoring event venue Mentoring event venue

Report on the 1st Startup Seminar

The “1st Startup Seminar” was held on Wednesday, August 28th.
This time, we had Mr. Nao Yoshizawa give a lecture titled “ Shikujiri Sensei.‘’ He taught me the basics of learning from past mistakes and building a strong business strategy without repeating the same mistakes.
Although the event was held only online due to the typhoon, more than 50 people participated.
The Startup Seminar will be held in a series of 5 sessions, so please join us next time.

Nao Yoshizawa

Speaker:
Bio-expert at the Cabinet Office, Lawyer, Patent Attorney, and Information Processing Engineer
Nao Yoshizawa

Report on the 1st Startup Seminar

Report on the 1st Startup Seminar

2024.09.19
There was a press release on the study of Dr. Takahisa Furukawa, the leader of R&D theme 5.
Ccrk-Mak/Ick signaling is a ciliary transport regulator essential for retinal photoreceptor survival
2024.09.17
Nobuhiro Nakai (Kobe University), a recipient of the PI Development Program, has been selected for the FY2024 “Advanced Research & Development Programs for Medical (AMED-PRIME)”. (in Japanese only.)
2024.08.28
There was a press release on the study of Dr. Hiroshi Seno, the leader of R&D theme 2.
Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning
2024.06.25
Atsushi Mitsuhashi (Tokushima University), a recipient of the PI Development Program, has been selected for the FY2023 “ Fusion oriented Research for disruptive Science and Technology (JST). (in Japanese only.)
2022.10.25
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
A high WBC count can predict atrial fibrillation: The Suita Study.
2022.08.24
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Serum uric acid levels associated with risk of diabetes mellitus in peri- and postmenopausal women living in urban areas.
2022.08.17
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Association of liver enzymes and alcohol intake with risk of developing diabetes mellitus among urban area residents.

When research related to this program or research using the equipment installed in the "Kento Imaging Support Center" is published in a paper, it will be introduced on the website of the Place for Co-Creation and reported to JST as an achievement.

[ Research related to this program ]
Please indicate your grant number below.
Grant number of the Co-Creation Field: JPMJPF2018
When your paper is accepted, please inform the Co-Creation Field Support Office.
We will publish your paper as a result on the website of Place for Co-Creation.

( For inquiries, please contact )
National Cerebral and Cardiovascular Center
Open Innovation Center, Industry-Academia Collaboration Division
6-1 Kishibe Shinmachi, Suita City, Osaka, Japan
E-mail: coi-next-so@ml.ncvc.go.jp
TEL: 06-6170-1070

List of TOPICS >

  • Northern Osaka Health and Biomedical Innovation Town KENTO
  • National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
  • National University Corporation Tokushima University
  • Eisai Co., Ltd.
  • Towa Pharmaceutical Co., Ltd.
  • Sysmex Corporation
  • Nipro Corporation
  • JSR Corporation
  • CYBERDYNE, Inc.
  • crossEffect, Inc.
  • CMIC HOLDINGS Co., Ltd.
  • Osaka Chamber of Commerce and Industry
  • Osaka Prefectural Government
  • Suita City
  • Settsu City
  • Mediford Corporation
  • Mizuho Bank, Ltd.
  • Kobe University
  • AIR WATER INC.
  • Kowa Company, Ltd.
  • JSPA(Japan Selfcare Promotion Association)
  • The SC approved MUFG Bank
  • Hankyu Hanshin Holdings Co., Ltd.
  • JCR Pharma Co., Ltd.
  • NEXGEN Co., Ltd.
  • Kyoto University
  • Osaka University
  • Shiga University of Medical Science
  • Kobe Pharmaceutical University
  • Osaka Metropolitan University
  • The Research Foundation for Microbial Diseases of Osaka University
  • Wellier Corporation
  • General Incorporated Association KENTO Co-Creation Promotion Organization (KCOP)